Showing results (81-90 of 164) with videos related to
Sort By:
Pageof 17
Pharmaceutics|June 27, 2025
<sup>99m</sup>Tc-Labeled Diarylpyrazoles for Single-Emission Computer Tomography Imaging of Neurotensin Receptor-Positive Tumors: A Comparative Preclinical StudyRoman Potemkin, Simone Maschauer, Harald Hübner, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis of a (68)ga-labeled peptoid-Peptide hybrid for imaging of neurotensin receptor expression in vivoSimone Maschauer, Jürgen Einsiedel, Carsten Hocke, et al.Bioorganic & Medicinal Chemistry|July 4, 2024
Structure-guided discovery of orexin receptor-binding PET ligandsKatharina Distler, Simone Maschauer, Eduard Neu, et al.Journal of Medicinal Chemistry|March 12, 2020
Investigation of Inactive-State κ Opioid Receptor Homodimerization via Single-Molecule Microscopy Using New Antagonistic Fluorescent ProbesAntonios Drakopoulos, Zsombor Koszegi, Yann Lanoiselée, et al.Bioorganic & Medicinal Chemistry|May 13, 2017
Development of molecular tools based on the dopamine D<sub>3</sub> receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behaviorAnne Stößel, Regine Brox, Nirupam Purkayastha, et al.Journal of Medicinal Chemistry|March 31, 2011
Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimeticsJürgen Einsiedel, Cornelia Held, Maud Hervet, et al.ACS Chemical Biology|January 13, 2021
Homobivalent Dopamine D<sub>2</sub> Receptor Ligands Modulate the Dynamic Equilibrium of D<sub>2</sub> Monomers and Homo- and HeterodimersTamara Ullmann, Marie Gienger, Julian Budzinski, et al.Journal of Medicinal Chemistry|November 2, 2011
Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific bindingFabian Kügler, Wiebke Sihver, Johannes Ermert, et al.Chemistryopen|December 6, 2014
Structure-based evolution of subtype-selective neurotensin receptor ligandsCarolin Schaab, Ralf Christian Kling, Jürgen Einsiedel, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2012
Novel azulene derivatives for the treatment of erectile dysfunctionStefan Löber, Harald Hübner, Armin Buschauer, et al.Pageof 17